Evidence map›Paper›PMID 39604091›Full record

ArticleJournal of analytical toxicology2025

Postmortem distribution of MDPHP in a fatal intoxication case.

Emma Beatrice Croce, Alexandra Dimitrova, Maria Grazia Di Milia, Stefano Pierotti, Davide Arillotta, Marta Barbaresi, Martina Focardi, Fabio Vaiano

Abstract readCase Reports
In one paragraph

Article in Journal of analytical toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Emma Beatrice CroceFT-LAB, Department of Health Science, University of Florence, Florence, 50134, Italy.
Alexandra DimitrovaFT-LAB, Department of Health Science, University of Florence, Florence, 50134, Italy.ORCID 0009-0001-4166-8010
Maria Grazia Di MiliaFT-LAB, Department of Health Science, University of Florence, Florence, 50134, Italy.
Stefano PierottiForensic Pathology Unit, Careggi University Hospital, Florence, 50134, Italy.
Davide ArillottaDepartment of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Florence, 50134, Italy.
Marta BarbaresiDepartment of Medicine and Surgery, Unit of Legal Medicine, University of Parma, Parma 43100, Italy.
Martina FocardiForensic Pathology Unit, Careggi University Hospital, Florence, 50134, Italy.
Fabio VaianoFT-LAB, Department of Health Science, University of Florence, Florence, 50134, Italy.ORCID 0000-0002-9256-4326

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synthetic cathinone (SC) 3,4-methylenedioxy-α-pyrrolidinohexanophenone (MDPHP) is structurally correlated to the 3,4-methylenedioxypyrovalerone (MDPV). In recent years, the number of intoxication cases has increased even if little is known about the pharmacokinetics properties. The Postmortem (PM) distribution of MDPHP remains largely unexplored. In these reports, MDPHP levels were quantified in blood, gastric content, and urine. This study aimed to describe the MDPHP PM distribution in several specimens, i.e. central and peripheral blood (CB and PB), right and left vitreous humor (rVH and lVH), gastric content (GCo), urine (U), and hair. The samples were collected from a cocaine-addicted 30-year-old man with a PM interval estimated in 3-4 h. Autopsy examination revealed unspecific findings, i.e. cerebral and pulmonary edema. No injection marks were observed. Toxicological analyses were performed using a multi-analytical approach: headspace gas chromatography for blood alcohol content (BAC), gas chromatography-mass spectrometry (GC-MS) for the main drugs of abuse, liquid chromatography-tandem mass spectrometry (LC-MS-MS) for benzodiazepines, and new psychoactive substances (NPS). BAC was negative (0.02 g/L). MDPHP concentrations were as follows: 1,639.99 ng/mL, CB; 1,601.90 ng/mL, PB; 12,954.13 ng/mL, U; 3,028.54 ng/mL, GCo; 1,846.45 ng/mL, rVH; 2,568.01 ng/mL, lVH; 152.38 (0.0-1.5 cm) and 451.33 (1.5-3.0 cm) ng/mg, hair. Moreover, hair segments were also positive for 3,4-dimethylmethcathinone (DMMC < limit of quantification: 0.01 ng/mg), α-PHP (0.59 ng/mg, 0.0-1.5 cm; 3.07 ng/mg, 1.5-3.0 cm), cocaine (6.58 ng/mg, 0.0-1.5 cm; 22.82 ng/mg, 1.5-3.0 cm), and benzoylecgonine (1.13 ng/mg, 0.0-1.5 cm; 4.30 ng/mg, 1.5-3.0 cm). MDPHP concentrations were significantly higher than those reported in the literature for fatal cases. For these reasons, the cause of death was probably the consumption of a lethal amount of MDPHP. Because CB and PB were similar, PM redistribution was not relevant.

Indexed as

AlkaloidsBenzodioxolesCocaine-Related DisordersPsychotropic DrugsPyrrolidinesAdultAutopsyChromatography, LiquidFatal OutcomeForensic ToxicologyGas Chromatography-Mass SpectrometryGastrointestinal ContentsHairHumansMaleSubstance Abuse DetectionAlkaloidsBenzodioxolesPsychotropic DrugsPyrrolidinesSynthetic Cathinone

Identifiers

PMID39604091
PMCPMC11982668

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.